CLINICAL_TRIALS
trial_result
· 2023-03-03
Clinical Trial Update: Open Label Extension of TUDCA-ALS Study [Phase 3]
Summary
Open-label extension update for a Phase 3 TUDCA-ALS trial investigating amyotrophic lateral sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Humanitas Mirasole SpA | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: UNKNOWN